Bausch Health Companies | VRX - Current Liabilities

Stock Price
7.48
Daily Change
-0.28 -3.61%
Monthly
-4.35%
Yearly
-6.38%
Q2 Forecast
7.29

Bausch Health Companies reported $4.18B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Amgen USD 25.49B 3.7B Dec/2025
ANI Pharmaceuticals USD 278.11M 7.56M Dec/2025
Aurora Cannabis CAD 145.94M 21.82M Dec/2025
Bausch Health Companies USD 4.18B 613M Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Canopy Growth CAD 98.29M 17.19M Dec/2025
Corcept Therapeutics USD 166.08M 6.18M Dec/2025
Danaher USD 6.81B 483M Dec/2025
Drreddys Laboratories INR 1.76B 62.5M Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
Nektar Therapeutics USD 53.54M 12.8M Dec/2025
Novo Nordisk DKK 215.66B 18.7B Dec/2025
Pacira USD 120.59M 13.51M Dec/2025
Perrigo USD 1.01B 132.4M Dec/2025
Phibro Animal Health USD 282.37M 12.23M Dec/2025
Prestige Brands USD 139.56M 4.95M Dec/2025
Supernus Pharmaceuticals USD 338.17M 7.54M Dec/2025
Vertex Pharmaceuticals USD 3.86B 614.1M Dec/2025
Zoetis USD 2.24B 428M Dec/2025